HemoGuard – AI-Based Thalassemia Screening

HemoGuard is an AI-powered digital health initiative from Center of Excellence in AI, Bahria University and SEECS, NUST that empowers individuals with insights into thalassemia minor carrier status using routine Complete Blood Count (CBC) reports — a non-invasive, cost-effective alternative to genetic testing. Our mission is to support early screening and awareness, reduce new thalassemia major births, and empower family planning decisions with smart technology. Key Highlights: • AI + CBC based non-invasive thalassemia carrier detection • NLP-driven screening recommendations • Backed by medical experts and national research grants • Collaborations with labs, universities & public health departments Join us in the fight against thalassemia. #HemoGuard #AIForHealth #ThalassemiaAwareness